Beneficial properties of melatonin in an experimental model of pancreatic cancer

Journal of Pineal Research

Volumn 43, Issue 3, 2007, Pages 270-275

  Ruiz Rabelo, Juan F ^a   Vázquez, Reyes ^a   Perea, María D ^a   Cruz, Adolfo ^a   González, Raul ^a   Romero, Ana ^a   Muñoz Villanueva, María C ^a   Túnez, Isaac ^b   Montilla, Pedro ^b   Muntané, Jordi ^a   Padillo, Francisco Javier ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Lipid peroxidation; Melatonin; Oxidative stress; Pancreatic cancer; Syrian hamster

Indexed keywords

ANTIOXIDANT; BIS(2 OXOPROPYL)NITROSAMINE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; MELATONIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PANCREAS ISLET CELL HYPERPLASIA; SYRIAN HAMSTER;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CRICETINAE; DISEASE MODELS, ANIMAL; LIPID PEROXIDES; MALE; MELATONIN; NITROSAMINES; PANCREATIC NEOPLASMS;

EID: 34548391467     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00472.x     Document Type: Article

References (30)

1. John L. Cameron. Current Surgical Therapy, 8th edn. Elsevier, Mosby, 2004.
2. Yeo CJ, Hruban RH, Conlon KC et al. Pancreatic cancer. J Am Coll Surg 1998 187 : 429 442.
3. American Gastroenterology Association. Technical review on epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999 117 : 1463 1484.
4. Li D, Xie K, Wolff R et al. Pancreatic cancer. Lancet 2004 363 : 1049 1057.
5. Neoptolemos JP, Stocken DD, Friess H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Eng J Med 2004 350 : 1200 1210.
6. Pino SM, Xiong HQ, Mcconkey D et al. Novel therapies for pancreatic adenocarcinoma. Curr Gastroenterol Rep 2004 6 : 119 125.
7. Dreher D, Junod AF. Review: role of oxygen free radicals in cancer development. Eur J Cancer 1996 32 : 30 38.
8. Rosen J, Than NN, Koch DK et al. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.
9. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives : A never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
10. Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004 37 : 213 214.
11. Meijers M, Van Garderen-Hoetmer A, Lamers CB et al. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. Carcinogenesis 1990 11 : 2223 2226.
12. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976 74 : 214 226.
13. Sun Y, Oberley LW, LI Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988 34 : 479 500.
14. Aebi H. Catalase in vitro. Meth Enzymol 1984 105 : 121 126.
15. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984 105 : 114 121.
16. Dianzani MU. Lipid peroxidation and cancer. Crit Rev Oncol Hematol 1993 15 : 125 147.
17. Gingell R, Wallcave L, Nagel D et al. Metabolism of the pancreatic carcinogens N-nitroso-bis(2-oxopropyl)amine and N-nitroso-bis(2-hydroxypropyl) amine in the Syrian hamster. J Natl Cancer Inst 1976 57 : 1175 1178.
18. Pour P, Althoff J, Krüger FW et al. A potent pancreatic carcinogen in Syrian golden hamster: N-nitroso-bis(2-oxopropyl)amine. J Natl Cancer Inst 1977 58 : 1449 1453.
19. Anisimov VN, Alimova IN, Baturin DA et al. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer 2003 103 : 300 305.
20. Kubatka P, Kalicka K, Chamilova M et al. Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats. Neoplasma 2002 49 : 255 259.
21. Wenger FA, Kilian M, Ridders J et al. Influence of antioxidative vitamins A, C and E on lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters. Prostagland Leukot Fatty Acids 2001 65 : 165 171.
22. Wenger FA, Kilian M, Jacobi CA et al. Effects of octreotide on liver metastasis and intrametastatic lipid peroxidation in experimental pancreatic cancer. Oncology 2001 60 : 282 288.
23. Woutersen RA, Appel MJ, Van Garderen-Hoetmer A. Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol 1999 37 : 981 984.
24. Hayes CJ, Whittaker BP, Watson SA et al. Synthesis and preliminary anticancer activity studies of C4 and C8-modified derivatives of catechin gallate (CG) and epicatechin gallate (ECG). J Org Chem 2006 71 : 9701 9712.
25. Cerutti P, Ghosh R, Oya Y et al. The role of the cellular antioxidant defense in oxidant defense in oxidant carcinogenesis. Environ Health Perspect 1994 102 : 123 129.
26. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
27. Tomás-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005 39 : 99 104.
28. Peschke E, Frese T, Chankiewitz E et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006 40 : 135 143.
29. Mühlbauer E, Peschke E. Evidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and β-cell. J Pineal Res 2007 42 : 105 106.
30. Bartsch C, Bartsch H. The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies. Cancer Causes Control 2006 17 : 559 571.